Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.
Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.
Amrize Ltd director Robert S. Rivkin reported the acquisition of 2,958 ordinary shares in the form of a restricted stock unit (RSU) award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award is recorded at a $0 price and is held directly following the transaction.
The RSUs vest on the earlier of the one-year anniversary of the grant and the issuer's next regular annual meeting of shareholders. The Form 4 shows the reported transaction date as 08/11/2025 and indicates the filing was made by one reporting person with an attorney-in-fact noted on the form.
Amrize Ltd (AMRZ) reports that director Roth Pellanda Katja Nicole received 2,958 ordinary shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The transaction is recorded as an acquisition and the award shows a reported price of $0, indicating the shares were granted rather than purchased.
The award vests on the earlier of the one-year anniversary of the grant date and the issuer's next regular annual meeting of shareholders, and following the transaction the reporting person beneficially owns 2,958 shares directly. No derivative securities were reported in this filing.
Oleas Jurg Amadeo, a director of Amrize Ltd (AMRZ), was granted 2,958 restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan on 08/11/2025 at a reported price of $0.
The award vests on the earlier of the one-year anniversary of the grant or the issuer's next regular annual meeting. After the grant, the reporting person beneficially owns 21,073 ordinary shares directly.
Amrize Ltd (AMRZ) reported a restricted stock unit award to director Michael E. McKelvy consisting of 2,958 ordinary shares granted under the Amrize Ltd 2025 Omnibus Incentive Plan. The grant is recorded as having a $0 price because it is a restricted stock unit award, and the reporting person is shown as the direct beneficial owner of 2,958 shares following the award.
The award vests on the earlier of the one-year anniversary of the grant date or the company’s next regular annual meeting of shareholders, which means the shares are subject to time-based vesting conditions before becoming transferable.
Amrize Ltd (AMRZ) disclosed that director Holli C. Ladhani received a restricted stock unit award for 2,958 ordinary shares under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was reported as an acquisition on 08/11/2025 at a reported price of $0 and is shown as direct beneficial ownership of 2,958 shares following the transaction. The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the issuer’s next regular annual meeting of shareholders, meaning the shares may convert to ownership within that timeframe if vesting conditions are met.
Gibson Dwight Audley Konrad, identified as a director of Amrize Ltd (AMRZ), was granted 2,958 ordinary shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was recorded as an acquisition at a $0 price and is held directly by the reporting person. The RSUs vest on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders. Following the reported transaction, the reporting person beneficially owns 2,958 shares.
Amrize Ltd director Nicholas C Gangestad was awarded 2,958 restricted stock units (RSUs) under the Amrize Ltd 2025 Omnibus Incentive Plan. The award is reported as an acquisition that results in 2,958 ordinary shares beneficially owned directly following the transaction and is recorded at a $0 price.
The RSUs vest on the earlier of the one‑year anniversary of the grant date and the issuer's next regular annual meeting of shareholders, creating a time‑based grant that converts to ordinary shares on vesting. No derivative securities were reported in this filing and no additional cash or material financial terms beyond the vesting condition and share count are disclosed.
Amrize Ltd (AMRZ) director Drew Theresa J was granted 2,958 restricted stock units (RSUs) under the Amrize Ltd 2025 Omnibus Incentive Plan, recorded as an acquisition on 08/11/2025. The award was issued at a $0 price and is reported as 2,958 ordinary shares beneficially owned by the reporting person following the transaction.
The RSUs vest on the earlier of the one-year anniversary of the grant and the issuer's next regular annual meeting of shareholders, creating alignment between the director and shareholders while representing a routine equity-compensation award that is modest in absolute size relative to typical market capitalization impacts. The Form 4 was filed by a single reporting person.
Jan Philipp Jenisch, who serves as Chairman & CEO and a director of Amrize Ltd (AMRZ), reported multiple purchases of the issuer's ordinary shares on 08/11/2025. The reporting person acquired 545,000 ordinary shares directly in several transactions priced roughly between $47.59 and $47.99. An additional 50,000 shares were acquired indirectly by the reporting persons spouse. Following these transactions, the filing shows 1,450,000 shares beneficially owned directly and 450,000 shares beneficially owned indirectly by the spouse. The prices reported reflect conversions from Swiss francs using an exchange rate of USD 1.00 = CHF 0.8084, and the filer offers to provide a full breakdown of the CHF-priced lots upon request.
Jan Philipp Jenisch, Chairman & CEO and director of Amrize Ltd (AMRZ), reported multiple purchases on 08/08/2025 totaling 500,000 ordinary shares — 100,000 acquired directly and 400,000 acquired indirectly by spouse. The trades were executed in Swiss francs at CHF 37.40–CHF 38.44 and converted at the transaction-date rate (USD 1.00 = CHF 0.8086), producing reported USD prices of approximately $46.25–$47.54 per share. Following these transactions the filing shows 905,000 shares beneficially owned directly and 400,000 shares beneficially owned indirectly by spouse. The Form 4 was signed by an attorney-in-fact on 08/12/2025.